chartexchange

BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire Inc. | Nov 13, 2026 5:15 PM EST

FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC with no actionable genomic alteration (AGA)

Read original article